Two new medical research centres will be funded by the Australian government to produce rapid improvements in preventing, treating and curing diabetes and cardiovascular disease, and their complications.

The government will provide $10 million each for the new research centres ($20 million overall), as well as $18 million to support translational research projects.

The Diabetes Research Centre’s translational research, development and implementation science activities will address three priority areas:

·       Diabetic kidney disease.

·       Peripheral neuropathy and diabetic foot syndrome.

·  Short term complications of hypoglycaemia and/or hyperglycaemic hyperosmolar syndrome (HHS) and ketoacidosis.

The priorities for the Cardiovascular Disease Research Centre will be:

·       Coronary artery disease (including angina and MACE)

·       Cardiomyopathy and heart failure

·       Transient ischaemic attack (TIA) and stroke (ischaemic and haemorrhagic).

Through a parallel program of research grants, $6 million will also be made available to develop innovative preventative, diagnostic, therapeutic and disease management products and solutions in priority areas.